Results 31 to 40 of about 896 (121)

Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)

Endocrinology, Diabetes & Metabolism Case Reports, 2023
A 31-year-old woman with complete androgen insensitivity syndrome (CAIS) experienced breast volume fluctuations during biphasic hormone replacement therapy consisting of estradiol and cyclical dydrogesterone, a progestin.
Benthe A M Dijkman, Christel J M de Blok, Koen M A Dreijerink, Martin den Heijer   +3 more
doaj   +1 more source

Successful pregnancy: simply about the complicated

Репродуктивная эндокринология
Progesterone is a key hormone essential for maintaining pregnancy. Its deficiency can lead to the risk of miscarriage, recurrent pregnancy loss, and unsuccessful attempts at in vitro fertilization.
T.F. Tatarchuk, V.I. Pyrogova, N.P. Goncharuk, N.Y. Pedachenko, D.G. Konkov   +4 more
doaj   +1 more source

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth

BMC Pregnancy and Childbirth, 2022
Background Preterm birth (PTB) remains a significant problem in obstetric care. Progesterone supplements are believed to reduce the rate of preterm labor, but formulation, type of administration, and dosage varies in different studies.
Fahimeh Alizadeh, Malihe Mahmoudinia, Masoumeh Mirteimoori, Lila pourali, Shabnam Niroumand   +4 more
doaj   +1 more source

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study

International Journal of Reproductive BioMedicine
Background: Currently, frozen embryo transfers (FET) account for 41% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only ...
Sahereh Arabian, Maryam Eftekhar, Saeideh Dashti, Nahid Homayoon, Elham Nikfarjam   +4 more
doaj   +1 more source

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto, Martha Gulati, Suvarna S. Khadilkar, Angela H. E. M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea R. Genazzani, Hema Divakar, Athena Poppas, on behalf of the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO)   +9 more
wiley   +1 more source

A comparison between the efficacy of dydrogesterone and calcium plus vitamin D in improving women’s general health [PDF]

, 2010
Objective: The aim of this randomized, double-blind, placebo-controlled clinical trial was to evaluate the effect of dydrogesterone and calcium plus vitamin D on young women's general health.
Tabatabaee, HR, Khajehei, M, Abdali, K
core   +1 more source

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue, Zachary Nash, Vikram Talaulikar, Shibani Nicum   +3 more
wiley   +1 more source

The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD) [PDF]

Терапевтический архив, 2018
Aim. To determine the effects of menopausal hormone therapy dosage on levels of proinflammatory cytokines and immunoglobulins in bodily fluids of patients with type 2 diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) during ...
A S Panevina, N S Smetneva, A M Vasilenko, M V Shestakova   +3 more
doaj   +1 more source

Recent trends on dydrogesterone in gynaecology, obstetrics, and infertility: insights from Indian experts [PDF]

Infertility affects millions globally, with significant prevalence in India due to conditions like endometriosis and polycystic ovarian syndrome (PCOS).
Khanna, Geeta, Dalal, Sachin, Suryawanshi, Sachin, Bakshi, Rita, Patki, Ameet, Kumar, Abhijeet, Parikshit Tank, Katke, Prashant, Tyagi, Rajul, Agarwal, Sweta, Pawar, Vijay, Vaidya, Rajan, Baxi, Asha   +12 more
core   +1 more source

Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix

, 2020
Objective: To compare the efficacy of dydrogesterone, 17-OH progesterone (17OHP) and oral or vaginal micronized progesterone with cerclage for the prevention of preterm birth in women with a short cervix.
Pustotina O.
core   +2 more sources